High Free Cash Flow Stocks
AFX.DE is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
CARL ZEISS MEDITEC AG - BR (AFX.DE) Stock Price & Overview
FRA:AFX • DE0005313704
Current stock price
26.48 EUR
+1.18 (+4.66%)
Last:
The current stock price of AFX.DE is 26.48 EUR. Today AFX.DE is up by 4.66%. In the past month the price increased by 9.42%. In the past year, price decreased by -55.72%.
AFX.DE Key Statistics
52-Week Range22.62 - 66.6
Current AFX.DE stock price positioned within its 52-week range.
1-Month Range24.32 - 28.36
Current AFX.DE stock price positioned within its 1-month range.
- Market Cap
- 2.368B
- P/E
- 18.14
- Fwd P/E
- 14.14
- EPS (TTM)
- 1.46
- Dividend Yield
- 2.08%
AFX.DE Stock Performance
Today
+4.66%
1 Week
-1.41%
1 Month
+9.42%
3 Months
-5.43%
Longer-term
6 Months -39.68%
1 Year -55.72%
2 Years -73.28%
3 Years -78.26%
5 Years -81.93%
10 Years -7.04%
AFX.DE Stock Chart
AFX.DE Stock Screens
AFX.DE currently appears in the following ChartMill screener lists.
Value Stocks with Strong Balance Sheets
AFX.DE is currently part of our value stocks with Strong Balance Sheets screen, indicating it cheap while meeting strict financial health and debt criteria.
Best Dividend Stocks
AFX.DE is currently part of our Best Dividend Stocks screen, indicating it pays a high and sustainable dividend.
Safe Dividend Stocks
AFX.DE occurs in our Safe Dividends Stock Screen, indicating it has a high and sustainable dividend, while being financially healthy
Undervalued Dividend Stocks
AFX.DE shows up in the Undervalued Dividend Stocks screen, indicating it is undervalued and has a solid dividend.
AFX.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to AFX.DE. When comparing the yearly performance of all stocks, AFX.DE is a bad performer in the overall market: 94.96% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
AFX.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE. AFX.DE has only an average score on both its financial health and profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AFX.DE Earnings
On February 12, 2026 AFX.DE reported an EPS of 0.03 and a revenue of 467.00M. The company missed EPS expectations (-88.15% surprise) and missed revenue expectations (-4.5% surprise).
Next Earnings DateMay 12, 2026
Last Earnings DateFeb 12, 2026
PeriodQ1 / 2026
EPS Reported€0.03
Revenue Reported467M
EPS Surprise -88.15%
Revenue Surprise -4.50%
AFX.DE Forecast & Estimates
23 analysts have analysed AFX.DE and the average price target is 34.53 EUR. This implies a price increase of 30.4% is expected in the next year compared to the current price of 26.48.
For the next year, analysts expect an EPS growth of -11.59% and a revenue growth 0.72% for AFX.DE
Analysts
Analysts66.09
Price Target34.53 (30.4%)
EPS Next Y-11.59%
Revenue Next Year0.72%
AFX.DE Financial Highlights
Over the last trailing twelve months AFX.DE reported a non-GAAP Earnings per Share(EPS) of 1.46. The EPS decreased by -17.51% compared to the year before.
Income Statements
Revenue(TTM)2.20B
Net Income(TTM)141.22M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.34% | ||
| ROA | 4.15% | ||
| ROE | 6.67% | ||
| Debt/Equity | 0.27 |
Chartmill High Growth Momentum
EPS Q2Q%-83.33%
Sales Q2Q%-4.79%
EPS 1Y (TTM)-17.51%
Revenue 1Y (TTM)5.89%
AFX.DE Ownership
Ownership
Inst Owners23.27%
Shares89.44M
Float34.64M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
AFX.DE Industry Overview
AFX.DE operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 35 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
39/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
70/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
34%
Outperformed 34% of sub-industries
3 Month Rank
30%
Outperformed 30% of sub-industries
6 Month Rank
32%
Outperformed 32% of sub-industries
Industry Fundamentals & Breadth
- Members
- 35
- New Highs
- 2.9%
- New Lows
- 11.4%
- Average ROE
- 9.8%
- Average Profit Margin
- 9.8%
- Average Operating Margin
- 14.8%
- Average P/E
- 15.6
- Average Fwd P/E
- 13.7
- Average Debt/Equity
- 0.6
AFX.DE Competitors/Peers
The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 13.05 | 87.766B | ||
| SHL | SIEMENS HEALTHINEERS AG | 13.17 | 39.345B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 14.77 | 21.56B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 14.76 | 21.55B | ||
| BIM | BIOMERIEUX | 14.88 | 8.486B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.4 | 3.731B | ||
| DIA | DIASORIN SPA | 14.33 | 3.246B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.01 | 1.679B | ||
| DRW8 | DRAEGERWERK AG | 8.61 | 1.313B | ||
| ELN | EL.EN. SPA | 17.32 | 1.052B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.95 | 969.315M | ||
| GVS | GVS SPA | 16.11 | 800.231M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About AFX.DE
Company Profile
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
Company Info
IPO: 2000-03-20
CARL ZEISS MEDITEC AG - BR
Goeschwitzer Strasse 51-52
Jena THUERINGEN DE
Employees: 5784
Phone: 493641220331
CARL ZEISS MEDITEC AG - BR / AFX.DE FAQ
What does AFX do?
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
What is the current price of AFX stock?
The current stock price of AFX.DE is 26.48 EUR. The price increased by 4.66% in the last trading session.
Does AFX stock pay dividends?
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a dividend yield of 2.08%. The yearly dividend amount is currently 0.6.
How is the ChartMill rating for CARL ZEISS MEDITEC AG - BR?
AFX.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists AFX stock?
AFX.DE stock is listed on the Frankfurt Stock Exchange exchange.
Is CARL ZEISS MEDITEC AG - BR (AFX.DE) expected to grow?
The Revenue of CARL ZEISS MEDITEC AG - BR (AFX.DE) is expected to grow by 0.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of AFX stock?
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a market capitalization of 2.37B EUR. This makes AFX.DE a Mid Cap stock.